MODIFICATION
A -- Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medicine Countermeasures - Solicitation 1
- Notice Date
- 6/8/2012
- Notice Type
- Modification/Amendment
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, Office of the Secretary, Acquisitions Management, Contracts, & Grants (AMCG), Office of the Assistant Secretary for Preparedness & Response (ASPR), Department of Health and Human Services, 330 Independence Ave. SW, G640, Washington, District of Columbia, 20201, United States
- ZIP Code
- 20201
- Solicitation Number
- BARDA-CBRN-BAA-12-100-SOL-00011
- Point of Contact
- Thomas P. Hastings-Tickerhoff, Phone: 202.720.2823, Matthew A. McCord, Phone: 202.260.0689
- E-Mail Address
-
thomas.hastings-tickerhoff@hhs.gov, matthew.mccord@hhs.gov
(thomas.hastings-tickerhoff@hhs.gov, matthew.mccord@hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Broad Agency Announcement - Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medicine Countermeasures BARDA encourages the advanced research, development and acquisition of medical countermeasures such as vaccines, therapeutics, and diagnostics, as well as innovative approaches to meet the threat of CBRN agents in support of the preparedness mission and priorities of the HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) articulated in the PHEMCE Implementation Plan for CBRN Threats. The Implementation Plan is located on the ASPR website: http://www.phe.gov/about/amcg/ard/Pages/default.aspx. In addition, the Pandemic and All Hazard Preparedness Act (PAHPA) directs BARDA to promote (i) innovations in technologies that may assist countermeasure and product advanced research and development (ii) research on and development of research tools and other devices and technologies and (iii) research to promote strategic initiations. The PAHPA is also located on the ASPR website: http://www.phe.gov/about/amcg/ard/Pages/default.aspx. The purpose of this BAA is to solicit proposals that focus on one or more of the following areas of interest as listed here and further described in Part I. Research Areas of Interest: 1. Vaccines Development 2. Antitoxins and Therapeutics 3. Antimicrobials and Antivirals 4. Radiological and Nuclear Agent Countermeasures 5. Chemical Agent Countermeasures 6. Diagnostics BARDA anticipates that research and development activities awarded from this Broad Agency Announcement (BAA) will serve to advance the knowledge and scientific understanding of candidates' countermeasures for CBRN threats toward eventual FDA approval and their inclusion in the Strategic National Stockpile (SNS). The Government intends to have a full & open competition for this requirement in the form of a BAA. The Government expects to make 1 or more awards, subject to the availability of funds. Contact Information: Comments to this announcement, referencing synopsis BARDA-CBRN-BAA-12-100-SOL-00011 may be submitted to CBRNBAA12.os@hhs.gov Pre-proposal Conference: Please note that a Pre-Proposal Conference will take place in Washington, DC at the Humphrey Building (DHHS Headquarters) on Monday, July 16. Please look in the posted BAA for information regarding time, registration, the call in number, and other attendance requirements. It is recommended that you register as soon as possible, as the room has a capacity limit.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/OOS/OASPHEP/BARDA-CBRN-BAA-12-100-SOL-00011/listing.html)
- Record
- SN02770401-W 20120610/120608235004-b2d44be66a0156a96c243e7d62b2567d (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |